Manufacturers and Distributors of AmniSure®—
A reliable, rapid and non-invasive test
for ROM (Rupture Of [fetal] Membranes)

“Recent data suggest that newer noninvasive tests such as the AmniSure ROM test may replace traditional clinical tests (nitrazine, pooling, and ferning) and amnio-dye tests in the diagnosis of preterm PROM.”
Reviews In Obstetrics & Gynecology, Winter 2008.  Caughey, AB, et al

“AmniSure® does not require the speculum examination used routinely for evaluation for ROM, and can
serve as one test that covers the entire spectrum of diagnostic necessity—from simple cases where confirmatory diagnosis is needed to the most difficult cases where no visible leakage of amniotic fluid is
evident or detectable by standard methods (sub-clinical rupture)."
American Journal of Perinatology, June 2005. Larry Cousins et al

“In conclusion, the placental alpha-microglobulin-- 1 immunoassay [i.e., AmniSure®] is a rapid and accurate method for confirming the diagnosis of ROM. Moreover, its performance appears to be superior to conventional clinical assessment (pooling, nitrazine, ferning) and the nitrazine test alone."
Journal of Obstetrics and Gynecology, March 2007, Lee et al

To enter, please select a language:

AmniSure® International LLC is registered with the FDA and certified to ISO13485:2003

tel: 617-234-4441 • info@amnisure.com